Claudins in cancer: bench to bedside

Area of Science:

• Cell Biology
• Molecular Biology
• Oncology

Background:

• Claudins are key integral membrane proteins forming tight junctions in mammals.
• Altered claudin expression (decreased, absent, or elevated) is observed in human neoplasias.
• Tight junction disruption is a hallmark of carcinogenesis, but claudins also play specific roles in tumorigenesis.

Purpose of the Study:

• To investigate the specific roles of claudins in cancer development and progression.
• To explore the dual function of claudins as oncogenic or tumor-suppressive factors.
• To establish claudins as potential biomarkers for cancer detection and diagnosis.

Main Methods:

• Analysis of claudin expression levels in various human cancers.
• Examination of claudin subcellular localization in pathological contexts.
• Correlation of claudin expression profiles with patient outcomes and prognosis.

Main Results:

• Claudin expression is dysregulated in various cancers, with specific roles depending on tissue and cell type.
• Claudins can act as oncogenes or tumor suppressors, influencing tumor development and progression.
• Expression patterns and localization of claudins are linked to patient prognosis in several cancer types.

Conclusions:

• Claudins are not merely structural components of tight junctions but also critical signaling molecules in cancer.
• Understanding claudin dysregulation is crucial for elucidating their role in tumorigenesis.
• Claudins hold significant potential as biomarkers for cancer detection, diagnosis, and prognosis.